BackgroundMetabolic syndrome is associated with formation of calcium oxalate (CaOx) uroliths in humans.ObjectivesTo investigate the association between obesity and hyperlipidemia with CaOx lower urinary tract uroliths in client‐owned dogs.AnimalsDogs with (n = 55, U [uroliths]‐dogs) and without (n = 39, UF [uroliths‐free]‐dogs) CaOx lower urinary tract uroliths.MethodsCase‐control study. U‐dogs were retrospectively enrolled and compared to UF‐dogs. Body condition score (BCS; 1‐9 scoring scale), serum triglyceride (TG) and total cholesterol (CH) concentrations and glycemia (after >12‐hour food withholding) were recorded in both groups.ResultsOn univariate logistic regression, when excluding Miniature Schnauzers, odds of having uroliths increased by a factor of 3.32 (95% CI 1.38‐11.12) for each mmol/L of TG (P = .027), of 39 (95% CI 9.27‐293.22) for each mmol/L of glycemia (P < .0001), and of 2.43 (95% CI 1.45‐4.45) per unit of BCS (P = .002). In multivariable models, the effect of TG was retained when all breeds were included for analysis and odds of having uroliths increased by a factor of 4.34 per mmol/L of TG (95% CI 1.45‐19.99; P = .02).Conclusions and Clinical ImportanceSerum lipid screening in dogs diagnosed with CaOx uroliths might be recommended to improve their medical staging and management.
Read full abstract